10.08.2023 CompuGroup Medical SE & Co. KGaA  DE000A288904

EQS-News: CompuGroup Medical launches AI initiative improving healthcare IT products and solutions


 

EQS-News: CompuGroup Medical SE & Co. KGaA / Key word(s): Miscellaneous
CompuGroup Medical launches AI initiative improving healthcare IT products and solutions

10.08.2023 / 07:24 CET/CEST
The issuer is solely responsible for the content of this announcement.


CompuGroup Medical launches AI initiative improving healthcare IT products and solutions

 

  • CGM AI Initiative launched in the second quarter
  • More face-to-face time with patients for doctors and healthcare practitioners
  • Strengthening R&D and business operations with high data protection standards
  • Continued investments into new technologies for the benefit of our customers
  • CGM well prepared for next level digital development in healthcare IT


Koblenz. CompuGroup Medical SE & Co. KGaA (CGM), one of the world's leading e-health providers, has launched an initiative in the second quarter to further extend the usage of Artificial Intelligence (AI), machine learning and large language models across the group. While already today several of CGM’s products and solutions are relying on AI based functions, there is significant potential for AI to shape and change the healthcare IT sector in the coming years. The benefits for doctors, healthcare practitioners, and patients are significant. Core AI fields for CGM customers range from chronic care management, prevention, diagnostics, population health management to improving operations and resource management, a key topic for doctors. Studies show that doctors and their teams spend 3-4 hours of administrative work for every hour actually dedicated to the wellbeing of their patients – AI based solutions will further reduce the inefficiencies in the healthcare ecosystem for the benefit of patients.

AI has been pushed as a key management priority at CGM. The team is focusing on the increasing use of Artificial Intelligence in products and solutions, to further enable the intelligent use of data while maintaining high data protection standards. At CGM, the new AI technology will be integrated into relevant areas and processes, from software development towards support processes, including customer service functions and administrative tasks.

When announcing the figures for the first half year 2023, CEO & CFO Michael Rauch described AI as a differentiating factor that will shape and change the healthcare IT sector in the coming years. Wisely used and safeguarding data privacy, AI offers significant advantages for doctors, hospitals, pharmacies, and patients. “The majority of patients trust Artificial Intelligence to support the doctor and would be willing to share their data for this purpose. We will help our customers making the difference, enabling them to spend more time with their patients, having sophisticated tools on their hands to improve healthcare.” says CEO & CFO Michael Rauch. “CGM is fully committed to deliver on our mission: We create the future of e-health.”

For the first half of 2023, CompuGroup Medical reported strong results across all segments. Group revenue increased by 15 % to EUR 595 million, with organic growth at 12 % compared to prior year. CGM continues to invest into research and development to drive innovation and to advance technology in the healthcare sector and confirms its guidance for 2023 with expected organic growth in group revenues of around 5 %.

 

Financial key figures

kEUR  Q2 2023  Q2 2022  Change  01.01.-30.06.2023  01.01.-30.06.2022  Change 
Revenues  304,179  265,047  + 15 %  595,022  516,696  + 15 % 
Recurring revenues in %  66 %  68 %  - 2 ppt  67 %  69 %  - 2 ppt 
Organic growth in %  13 %  3 %  + 10 ppt  12 %  4 %  + 8 ppt 
EBITDA adjusted  73,144  53,594  + 36 %  133,093  105,110  + 27 % 
EBITDA margin adjusted  24 %  20 %  + 4 ppt  22 %  20 %  + 2 ppt 
EPS adjusted (EUR) - diluted  0.62  0.40  + 55 %  1.07  0.82  + 30 % 
Free cash flow  4,031  - 36,492  + 111 %  82,534  28,117  + 194 % 
Number of shares outstanding (‘000)        52,235  52,235  + 0 % 

 

The full half-year financial report is available on the company's website at www.cgm.com/ir-publications.


About CompuGroup Medical SE & Co. KGaA

CompuGroup Medical is one of the leading e-health companies in the world. With a revenue base of EUR 1.130 billion in 2022, its software products are designed to support all medical and organizational activities in doctors’ offices, pharmacies, laboratories, hospitals, and social welfare institutions. Its information services for all parties involved in the healthcare system and its web-based personal health records contribute towards safer and more efficient healthcare. CompuGroup Medical’s services are based on a unique customer base of more than 1.6 million users, including doctors, dentists, pharmacists and other healthcare professionals in inpatient and outpatient facilities. With locations in 21 countries and products in 60 countries worldwide, CompuGroup Medical is the e-health company with one of the highest coverages among healthcare professionals. More than 9,200 highly qualified employees support customers with innovative solutions for the steadily growing demands of the healthcare system.



10.08.2023 CET/CEST Dissemination of a Corporate News, transmitted by EQS News - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.eqs-news.com


Language: English
Company: CompuGroup Medical SE & Co. KGaA
Maria Trost 21
56070 Koblenz
Germany
Phone: +49 (0)160 3630362
Fax: +49 (0)261 8000 3200
E-mail: [email protected]
Internet: www.cgm.com
ISIN: DE000A288904
WKN: A28890
Indices: SDAX, TecDAX
Listed: Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Munich, Stuttgart, Tradegate Exchange
EQS News ID: 1700289

 
End of News EQS News Service

1700289  10.08.2023 CET/CEST

fncls.ssp?fn=show_t_gif&application_id=1700289&application_name=news&site_id=boersengefluester_html


Die wichtigsten Finanzdaten auf einen Blick
  2017 2018 2019 2020 2021 2022 2023e
Umsatzerlöse1 582,38 717,02 745,81 837,26 1.025,32 1.129,74 1.187,66
EBITDA1,2 128,44 187,84 178,13 197,48 213,39 216,35 229,76
EBITDA-Marge3 22,05 26,20 23,88 23,59 20,81 19,15
EBIT1,4 90,07 143,23 115,27 121,77 102,68 104,03 113,96
EBIT-Marge5 15,47 19,98 15,46 14,54 10,01 9,21 9,60
Jahresüberschuss1 31,74 96,34 66,15 73,42 69,03 74,12 46,87
Netto-Marge6 5,45 13,44 8,87 8,77 6,73 6,56 3,95
Cashflow1,7 85,82 136,35 110,50 149,93 165,27 145,03 179,53
Ergebnis je Aktie8 0,63 1,92 1,33 1,40 1,30 1,40 0,88
Dividende8 0,35 0,50 0,50 0,50 0,50 0,50 0,35
Quelle: boersengefluester.de und Firmenangaben

  Geschäftsbericht 2023 - Kostenfrei herunterladen.  
1 in Mio. Euro; 2 EBITDA = Ergebnis vor Zinsen, Steuern und Abschreibungen; 3 EBITDA in Relation zum Umsatz; 4 EBIT = Ergebnis vor Zinsen und Steuern; 5 EBIT in Relation zum Umsatz; 6 Jahresüberschuss (-fehlbetrag) in Relation zum Umsatz; 7 Cashflow aus der gewöhnlichen Geschäftstätigkeit; 8 in Euro; Quelle: boersengefluester.de

Wirtschaftsprüfer: KPMG

INVESTOR-INFORMATIONEN
©boersengefluester.de
CompuGroup Medical
WKN Kurs in € Einschätzung Börsenwert in Mio. €
A28890 28,500 Halten 1.531,44
KGV 2025e KGV 10Y-Ø BGFL-Ratio Shiller-KGV
21,92 35,77 0,61 24,46
KBV KCV KUV EV/EBITDA
2,49 8,53 1,29 9,62
Dividende '22 in € Dividende '23e in € Div.-Rendite '23e
in %
Hauptversammlung
0,50 1,00 3,51 22.05.2024
Q1-Zahlen Q2-Zahlen Q3-Zahlen Bilanz-PK
08.05.2024 08.08.2024 07.11.2024 28.03.2024
Abstand 60Tage-Linie Abstand 200Tage-Linie Performance YtD Performance 52 Wochen
-5,57% -21,42% -24,80% -42,75%
    
Weitere Ad-hoc und Unternehmensrelevante Mitteilungen zu CompuGroup Medical SE & Co. KGaA  ISIN: DE000A288904 können Sie bei EQS abrufen


Software , A28890 , COP , XETR:COP